Zirus Antivirotics

Zirus Antivirotics

Zirus

antivirotics, gene trap, H1N1, influenza, macrophage, Pandemic, Swine Flu, Vaccine, viral infection, Zirus, XVIVO

Scientists at Zirus are working on a new technology platform to cure and manage viral infection through the development of new classes of antivirotics. This animation depicts the life cycle of H1N1 influenza-A virus and the methodology Zirus uses to find appropriate targets.

Watch the NPR featured story on Zirus Antivirotics by Robert Krulwich.

“I reviewed the video this morning and think it looks truly exceptional—I had high expectations to begin with and you have actually exceeded them.”
CEO, Threshold Pharmaceuticals